Home/Filings/4/0001144204-16-128961
4//SEC Filing

INTERLEUKIN GENETICS INC 4

Accession 0001144204-16-128961

CIK 0001037649operating

Filed

Oct 20, 8:00 PM ET

Accepted

Oct 21, 4:05 PM ET

Size

5.6 KB

Accession

0001144204-16-128961

Insider Transaction Report

Form 4
Period: 2016-10-20
Toutain Stephan
Chief Commercial Officer
Transactions
  • Award

    Stock Option (Right to Buy)

    2016-10-20+3,738,9333,738,933 total
    Exercise: $0.18Exp: 2026-10-20Common Stock (3,738,933 underlying)
Footnotes (2)
  • [F1]The exercise price of the option is the closing price of the Issuer's common stock on the OTCQB on October 20, 2016, which was the grant date of the option.
  • [F2]The option vests as to 25% of the shares on August 15, 2017, and 1/36th of the shares on the first day of each month beginning on September 1, 2017.

Issuer

INTERLEUKIN GENETICS INC

CIK 0001037649

Entity typeoperating
IncorporatedDE

Related Parties

1
  • filerCIK 0001037649

Filing Metadata

Form type
4
Filed
Oct 20, 8:00 PM ET
Accepted
Oct 21, 4:05 PM ET
Size
5.6 KB